Radium bromide the air causes this luminescence. Radium bromide is also very dangerous since the crystals occasionally explode. Helium gas evolved from alpha particles can accumulate within the crystals which cause them to weaken and rupture. Another property of radium bromide is its ability to crystallize from an aqueous solution. It forms a dihydrate, very similar to barium bromide. The chemical radium bromide is not found in nature; it is created. To extract radium from uranium or pitchblende ores, the most common practice is called the Curie method which it involves two major stages. The first stage is a chemical treatment to
Radium-223 kBq/ml), sodium chloride, and other ingredients for intravenous injection. Algeta ASA was later acquired by Bayer who is now the sole owner of Xofigo. The recommended regimen is six treatments of 55 kBq/kg (1.3 uCi per kg), repeated at 4-week intervals. The use of radium-223 to treat metastatic bone cancer relies on the ability of alpha radiation from radium-223 and its short-lived decay products to kill cancer cells. Radium is preferentially absorbed by bone by virtue of its chemical similarity to calcium, with most radium-223 that is not taken up by the bone being cleared, primarily via the gut, and